Revolution Medicines
🏷️ Oncology
🏷️ Biotech
🏷️ Pharmaceuticals
Revolution Medicines is a commercial-stage oncology company that discovers, develops and delivers medicines for patients with RAS-addicted cancers. The company leverages a differentiated RAS(ON) tri-complex inhibitor platform to advance a portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS.
v
